Serina Therapeutics, Inc.
Developing safer, more effective drugs for neurology and cancer using polymer technology.
SER | US
Overview
Corporate Details
- ISIN(s):
- US00848H1086 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 601 GENOME WAY, 35806 HUNTSVILLE
- Website:
- https://serinatherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Serina Therapeutics, Inc. is a clinical-stage biotechnology company developing a pipeline of drug candidates using its proprietary polyoxazoline (POZ) polymer technology. This platform is designed to improve the performance of small molecule drugs by enhancing their safety, efficacy, and tolerability, thereby addressing toxicity challenges and reducing development risk. The company focuses on creating novel therapeutics for neurological diseases, such as Parkinson's disease, as well as for cancer, pain, and inflammation. By optimizing proven drugs, Serina aims to redefine the standard of care in its target therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Serina Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Serina Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Serina Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
